Danaher Corporation (DHR): Executive Vice President sold ~$275K

~$275K

Approx. value · 1,320 sh @ $208.01

5,099

Holds after · shares reported

Traded

Feb 19, 2026

Filed

Feb 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Apr 28, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
2. Dec 18, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
3. Dec 23, 2025FDARecall: CellMek SPS Sample Preparation System, REF: C44603, with software
4. Jan 12, 2026Company filing · Form 8-K · ResultsReported its results
5. Jan 16, 2026FDAFDA device clearance: Xpert GI Panel
6. Jan 27, 2026FDAFDA device clearance: Access anti-HAV IgM
7. Jan 28, 2026Company filing · Form 8-K · ResultsReported its results
8. Jan 30, 2026FDARecall: CHEMISTRY ANALYZER AU5800, REF: B96697, B96698, B23279, B23280, B23281
9. Jan 30, 2026FDARecall: DxC 700 AU, REF: B86444, B86446
10. Jan 30, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 8.6%
11. Feb 5, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 5, 2026, Jessica L. Mega notified Danaher Corporation’s (“Danaher”) Board of Directors (“Board”) of her retirement from the Board as of February 5, 2026, due to commitments related to her other professional obligations.”
12. Feb 19, 2026 · this disclosureInsiderOfficer sold ~$275K of DHR shares in the open market

What came next

1. Feb 19, 2026FDAFDA device clearance: Access anti-HBc Total
2. Feb 20, 2026FDAFDA device clearance: Xpert Hemorrhagic Fever
3. Mar 13, 2026FDAFDA device clearance: Access anti-HBc IgM
4. Mar 16, 2026FDARecall: Access Total T4 Calibrator, Catalog No. 33805
5. Mar 24, 2026FDAFDA device clearance: Access BNP II
6. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
7. Apr 10, 2026FDAFDA device clearance: ABL90 FLEX PLUS System, safeCLINITUBES
8. Apr 16, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
9. Apr 21, 2026Company filing · Form 8-K · ResultsReported its results
10. Apr 22, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
11. Apr 29, 2026FDARecall: REMISOL Advance with Software Version 2.5 UDI-DI code: 15099590802073 The Normand Info REMISOL Advance Data Manager collects and manages data and workflow for…
12. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.7%
13. May 1, 2026FDAFDA device clearance: ABL90 FLEX PLUS System
14. May 1, 2026FDAFDA device clearance: ABL90 FLEX PLUS System
15. May 1, 2026InsiderDirector sold ~$237K of DHR shares in the open market
16. May 5, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 5, 2026, at the annual meeting of shareholders (the “Annual Meeting”) of Danaher Corporation (the “Company”), as further described in Item 5.07 below, the Company’s shareholders approved the Amended and Restated Danaher Corporation Omnibus Incentive Plan (the “Plan”).”
17. Jun 3, 2026Company filing · Form 8-K · New debt, Other newsTook on new debt or obligations, and reported other company news

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

Other recent filings by Gregory M Milosevich, Executive Vice President

• SEC Form 4 at Danaher Corporation (DHR)Nov 10, 2026

The full history of Gregory M Milosevich, Executive Vice President is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Danaher Corporation

• SEC Form 144Nov 10, 2026
• SEC Form 4Nov 10, 2026
• SEC Form 4Nov 10, 2026
• SEC Form 144Nov 9, 2026
• SEC Form 144Nov 9, 2026
• SEC Form 144Nov 9, 2026

Everything OQRO holds on this company is on its DHR page.